February 24, 2022
MADISON, Wis. -- Mirus Bio LLC, a leading provider of delivery solutions within Gamma Biosciences, today launched TransIT-VirusGEN® SELECT Transfection Kits for large-scale viral vector production for cell and gene therapy applications. The kits support pre-clinical and process development activities and consist of the TransIT-VirusGEN Transfection Reagent, complex formation solution and enhancer. The full kits are designed to improve the [...]
Biotage Awarded Gold Sustainability Medal by EcoVadis
February 24, 2022
We help shape the sustainable science of tomorrow and our future society for the benefit of humankind – HumanKind Unlimited. With this principle Biotage has set out a commitment to unleashing the potential of humanity by working tirelessly to improve the health and wellbeing of both our customers through greener and more efficient solutions, and [...]
February 24, 2022
Element Biosciences and Jumpcode Genomics partner to improve next-generation DNA sequencing. Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a collaboration and co-marketing partnership with Jumpcode Genomics that validates Jumpcode's CRISPRclean® technology on Element’s AVITI™ System. The partnership has already demonstrated the value of pairing the technologies, promising improved data quality and [...]
February 24, 2022
SAN DIEGO -- Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Dovetail Genomics demonstrating the value and performance of Dovetail’s proximity ligation-based next-generation sequencing (NGS) library prep solutions on Element’s AVITI System. The ability to unlock access to genomic structure enables cutting-edge science in the fields [...]
Benchling Acquires Overwatch Research to Accelerate Breakthroughs for Biopharma Companies
February 24, 2022
R&D Cloud leader makes acquisition to create the industry’s first comprehensive, cloud-native in vivo solution and deepen its presence in Europe SAN FRANCISCO — Benchling, pioneer of the R&D Cloud powering the biotechnology industry, announced it has acquired Overwatch Research, a Belfast-based startup creating software to accelerate in vivo research. Overwatch’s configurable, end-to-end study management and [...]
February 24, 2022
The SOPHiA DDM HRD Solution offers cost-effective, accurate, reliable, timely, and easily implementable in-house results to empower better clinical research decisions BOSTON, United States and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, announced today the launch of their SOPHiA DDM Homologous Recombination Deficiency (HRD) Solution, opening new doors for cancer research. The [...]
Eagle Genomics Continues Strategic Global Expansion with Three New Appointments in UK and India
February 24, 2022
Cambridge, UK – Today, Eagle Genomics, the Deep Tech platform business pioneering the application of network science to biology across the Food and Nutrition, Beauty and Personal Care, AgBio and Biopharma industries, announced three new senior appointments in the UK and India as the company’s global growth continues to accelerate at pace. This includes bioinformatics veteran Dr. Nandu [...]
Max Analytical Technologies Acquired by Thermo Fisher Scientific
February 24, 2022
Max Analytical Technologies Acquired by Thermo Fisher Scientific Locally Developed Company Acquired by World Leader in Serving Science MOUNT PLEASANT, Mich. — Central Michigan University Research Corporation (CMURC) announces the acquisition of portfolio company MLS ACQ, Inc. (DBA - Max Analytical Technologies), a chemical instrumentation company founded in Mount Pleasant, Mich. Max Analytical was acquired [...]
Fulgent Genetics Announces Strategic Investment in Spatial Genomics
February 23, 2022
Strategic investment and partnership brings Spatial’s multiomics platform and seqFISH technology to Fulgent’s comprehensive suite of genomic testing solutions TEMPLE CITY, Calif. & PASADENA, Calif. -- Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today [...]
BD Appoints Shana Neal as Chief People Officer
February 23, 2022
FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Shana Neal has been appointed chief people officer, effective April 4, 2022. Neal, who held HR leadership positions at BD from 2005 to 2018, will oversee BD's Human Resources, Communications and Social Investing functions globally, [...]

